Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.

Kosaka, Makoto; Ozaki, Akihiko; Kaneda, Yudai; Saito, Hiroaki; Yamashita, Erika; Murayama, Anju; Mamada, Hanano; Tanimoto, Tetsuya; Jakovljevic, Mihajlo

Kosaka, Makoto; Ozaki, Akihiko; Kaneda, Yudai; Saito, Hiroaki; Yamashita, Erika; Murayama, Anju; Mamada, Hanano; Tanimoto, Tetsuya; Jakovljevic, Mihajlo.

Afiliação

Kosaka M; Imamura Hospital Kagoshima, Kagoshima, Japan.
Ozaki A; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Kaneda Y; Department of Breast and Thryoid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
Saito H; School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Yamashita E; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Murayama A; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Mamada H; School of Medicine, Tohoku University, Sendai, Miyagi, Japan.
Tanimoto T; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Jakovljevic M; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.

Cost Eff Resour Alloc ; 21(1): 35, 2023 May 31.

Article em En | MEDLINE | ID: mdl-37259132

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão